Top Story

Keith C. Ferdinand, MD, highlights recent data on link between CVDs, diabetes drugs

October 30, 2014

BOSTON — At the Cardiometabolic Health Congress, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New Orleans, outlines recent trial data and FDA updates related to CV and diabetes care.

During a session, Ferdinand discussed a trial that assessed the impact of the GLP-1 agonist dulaglutide on BP and heart rate in a cohort of 755 patients. Ferdinand, who was the principal investigator for the trial, noted a small increase in heart rate with dulaglutide 1.5 mg compared with placebo, but similar results between placebo and dulaglutide 0.75 mg. Patients who received the 1.5 mg dose also exhibited a significant decrease in BP during a 24-hour period. He noted that, while the trial did not assess CV outcomes, results suggest that GLP-1 agonists may aid in BP control, although long-term outcome trials should be performed to determine whether the observed heart rate increase is potentially problematic.

figure Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or metabolic disease poses…
figure Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the Cardiometabolic Health…
In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study findings published in…
CME
figure

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »
Meeting News Coverage Video
figure

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
figure

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »

Filter By:

In the Journals

CABG, newer-generation DES yielded similar mortality rates in patients with diabetes

June 26, 2014
Comparable mortality rates were reported for patients with diabetes treated with CABG or PCI using a cobalt-chromium everolimus-eluting…
FDA News

FDA: No clear link between olmesartan, CV risk among patients with diabetes

June 24, 2014
The FDA today announced that a safety review of olmesartan indicates no increased risk for CV events among patients with diabetes.According to a…
Meeting News Coverage Perspective

Empagliflozin reduced BP for patients with type 2 diabetes, hypertension

June 23, 2014
CHICAGO — In patients with type 2 diabetes and hypertension, empagliflozin significantly reduced BP in addition to improving blood glucose…
Meeting News Coverage

More than 10% of patients with acute MI may have undiagnosed diabetes

June 16, 2014
It is estimated that about 10% of patients with MI may also have undiagnosed diabetes, according to new research presented at the American Heart…
Meeting News Coverage

OGTT after MI reveals high undiagnosed diabetes, subsequent high mortality

June 14, 2014
SAN FRANCISCO — New research looking at oral glucose tolerance testing 4 days after both ST-elevation myocardial infarction and non-ST-elevated…
Meeting News Coverage Perspective

Experts debate ACC/AHA lipid guidelines

June 13, 2014
SAN FRANCISCO — Two researchers argued whether or not the recently issued American College of Cardiology and American Heart Association…

Groups launch clinical registry to track, improve quality of diabetes and cardiometabolic care

June 11, 2014
The American College of Cardiology, in collaboration with the American Diabetes Association, American College of Physicians and Joslin Diabetes…
In the Journals

Diabetes yielded negative clinical, economic outcomes after CABG

June 9, 2014
Patients in China with diabetes who were undergoing CABG incurred higher costs and had poorer long-term results than patients without diabetes…
Meeting News Coverage

Weight loss at any age can result in long-term CV benefit

May 22, 2014
A decrease in BMI category at any age in adulthood was associated with improvement in CV risk factors, even if the weight loss was not sustained…
Meeting News Coverage Video

Video: Shared factors of cardiovascular risk and metabolic health in women

May 22, 2014
Endocrine Today caught up with Yehuda Handelsman, MD, FACP, FACE, FNLA, president-elect of the American College of Endocrinology, at AACE’s…
More Headlines »